Leukapheresis Market Size, Share, Trends, Growth and Forecast 2032

Leukapheresis Market Insights

According to the report published by Zion Market Research, the global Leukapheresis Market size was valued at USD 216.81 Million in 2023 and is predicted to reach USD 437.02 Million by the end of 2032. The market is expected to grow with a CAGR of 8.1% during the forecast period. The report analyzes the global Leukapheresis Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Leukapheresis industry.

Request Free Sample

Global Leukapheresis Market: Overview

Leukapheresis is a laboratory method in which white blood cells are separated from a sample of blood. It is a particular kind of apheresis, the more general term for separating out one specific constituent of blood and returning the remainder to the circulation. Leukapheresis can be performed to reduce a very high white blood cell count and obtain autologoU.S. blood cells for research purpose and then later transplant them back into the patient’s body. Precisely, Leukapheresis is an exceptionally performed blood donating procedure.

Global Leukapheresis Market: Growth Factors

Increasing incidence and prevalence of leukemia, burgeoning demand for leukopaks for research applications, and rise in the blood donations are few of the factors that are anticipated to drive the Leukapheresis market size in the coming years.  Researchers across the globe are exploring new fields such as pediatrics for applying Leukapheresis and this, in turn, will further boost Leukapheresis market scope in the near future.

However, massive costs of therapeutic Leukapheresis and leukopaks along with strict government legislations governing selecting of leukocyte donor will adversely impact the growth of Leukapheresis market in the years to come. In addition, complexities related to therapeutic Leukapheresis may further put brakes on the expansion of the market growth in the coming decade. Nevertheless, the massive acceptance of the procedure for isolating the white blood corpU.S.cles for research activities including development of cell-based immunotherapies will create plethora of growth opportunities for market players operating in the Leukapheresis market.

Request Free Sample

Global Leukapheresis Market: Segmentation

The global Leukapheresis market can be divided based on product, leukopaks, application, and end U.S.er. Based on the product, the market is segmented into Apheresis Machine, Leukocyte Filter, Column, and Disposables. On the basis of leukopaks, the Leukapheresis market is classified into human primary cells, mobilized cells, and non-mobilized cells. Application wise, the market is sectored into research and therapeutic applications. Based on the end U.S.er, the market is divided into hospitals and research institutes.

Leukapheresis Market: Report Scope

Global Leukapheresis Market: Regional Analysis

Based on regions, the global Leukapheresis market can be divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2018, Asia Pacific was anticipated to account for the largest share of the Leukapheresis products and leukopaks market, followed by North America and Europe. Asia Pacific’s prominent growth in the Leukapheresis market can be attributed to the increase in regenerative medicine research in the region, rise in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focU.S.ing on cell therapy research in the region.

Increase in government investments as well as private funding of biotechnology research in countries such as the U.S. and Canada in North America along with rise in the ongoing research & development activities in the pharmaceutical sector will provide momentum to the growth of Leukapheresis market in the coming years. In addition, many of the reputed pharmaceutical & biotech firms have their headquarters in the country such as the U.S. and this, in turn, is likely to provide huge impetU.S. to the Leukapheresis market size growth in the region.

European region possesses huge market growth potential and market will register a commendable growth in the region within the next few years.

Global Leukapheresis Market: Competitive Players

The key players of the global Leukapheresis market include :

• Asahi Kasei Medical (Japan)
• FreseniU.S. (Germany)
• Haemonetics (U.S.)
• Terumo BCT (U.S.)
• STEMCELL Technologies (Canada)
• Macopharma (France).

The Global Leukapheresis Market is segmented as follows:
 
By product 

• Apheresis Machine
• Leukocyte Filter 
• Column
• Disposables 

By leukopaks 

• human primary cells
• mobilized cells
• non-mobilized cells 

By Application 

• research
• therapeutic applications 

By End User 

• hospitals 
• research institutes

Global Leukapheresis Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • The UK
  • France
  • Germany
• The Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.